Introduction
The green biotech industry in South Korea, which transforms local agricultural products into high-value health foods and cosmetics, is experiencing rapid growth. However, a recent study highlights that fewer than 10% of companies in this sector have ventured into international markets. This article explores the current state of the industry, identifying barriers and potential strategies for enhancing market access and growth.
Domestic Ingredient Utilization
A significant feature of South Korea’s green biotech firms is their reliance on domestic ingredients, with 75.5% of raw materials sourced locally. This reliance supports the local agricultural economy and ensures the freshness of inputs. However, the methods of securing these ingredients reveal challenges within the industry. Most companies procure their ingredients through external suppliers (43.5%), while self-cultivation and contract farming account for smaller shares at 16.5% and 13.9%, respectively. The limited use of contract farming, which allows for pre-agreed terms with growers, suggests a need for better integration within the supply chain.
Research and Development Shortcomings
Despite the high domestic ingredient usage, only 19.9% of the surveyed firms have dedicated research and development (R&D) units. This lack of focus on R&D is concerning, especially as the industry seeks to innovate and develop high-quality products that meet international standards. Moreover, only 15% of companies possess licensed health functional food products, indicating a gap in product validation and commercialization processes.
Quality Control and Certification Issues
Quality control remains a significant concern within the green biotech sector. While 68.6% of firms claim to have experience in producing functional products, only 31.4% have established quality control units. Furthermore, certifications such as Good Manufacturing Practice (GMP) and ISO are held by just 31.4% and 18.7% of companies, respectively. These statistics underscore the need for enhanced quality management systems to ensure that products can compete in global markets.
Barriers to Market Entry
The report from the Korea Rural Economic Institute emphasizes that the underdeveloped state of supply chains, quality standardization, and certification processes hinders the industry’s ability to produce high-value products. The fragmentation of support systems across various government ministries further complicates the situation, leading to inefficiencies in translating research outcomes into market-ready products. In contrast, successful models in countries like Japan and the EU have demonstrated the importance of cohesive policies that integrate R&D with commercialization.
Proposed Solutions for Growth
To address these challenges, the institute advocates for an end-to-end support framework that connects raw material production, ingredient development, and product commercialization. This comprehensive approach would facilitate stable sourcing, quality standardization, functional verification, and smoother entry into overseas markets. Strengthening support for international certification and developing regional hub facilities are also crucial steps toward enhancing the industry’s global competitiveness.
Future Prospects
The green biotech industry represents a significant opportunity for growth, linking agriculture with food, biotech, and healthcare sectors. Experts argue that with a robust support framework that aligns government policy with real-world implementation, South Korea can enhance the added value of its agricultural products and bolster the competitiveness of its green biotech sector on the global stage.
Conclusion
As South Korea’s green biotech industry continues to evolve, overcoming existing barriers will be essential for unlocking its full potential. By improving R&D capabilities, enhancing quality control, and fostering cohesive government support, the sector can position itself for successful expansion into international markets, ultimately benefiting both the economy and public health.
Key Takeaways
- South Korea’s green biotech sector relies heavily on domestic ingredients but faces challenges in sourcing and procurement.
- Research and development capabilities are limited, with only 19.9% of firms having dedicated R&D units.
- Quality control and certification are critical areas needing improvement to facilitate market entry.
- An integrated support framework could drive growth and enhance global competitiveness.
- The industry’s future relies on aligning government policies with industry needs for sustainable development.
Read more → biz.heraldcorp.com